HAL (France)
open access
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Interplay between medical and interventional therapies in valvular heart disease and heart failure: an expert opinion paper.#135594
- Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine#979527
- REMAP ECMO - Beta Receptor Modulation Trial#1046632
- Baxdrostat and Ventricular Remodeling#1115104
- Serratus Anterior Plane Block for Improving Pain and Respiratory Function in Patients With Multiple Rib Fractures#848231
Record · ID 226812
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive